Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program.
Saved in:
| Title: | Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program. |
|---|---|
| Authors: | Galluppi GR; Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts, USA., Brar S; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA., Caro L; Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Chen Y; Department of Drug Metabolism and Pharmacokinetics, Genentech Inc., a member of the Roche Group, South San Francisco, California, USA., Frey N; Roche Pharma Research and Exploratory Development, Pharmaceutical Science, Roche Innovation Center, Basel, Switzerland., Grimm HP; Roche Pharma Research and Exploratory Development, Pharmaceutical Science, Roche Innovation Center, Basel, Switzerland., Rudd DJ; Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Li CC; Department of Clinical Pharmacology, Genentech, member of the Roche group, South San Francisco, California, USA., Magee M; GlaxoSmithKline, Philadelphia, Pennsylvania, USA., Mukherjee A; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA., Nagao L; Faegre Drinker Biddle & Reath, LLP, Washington, DC, USA., Purohit VS; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA., Roy A; Bristol Myers, Inc., Woodbury, Connecticut, USA., Salem AH; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, Illinois, USA.; Ain Shams University, Cairo, Egypt., Sinha V; Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Suleiman AA; Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany., Taskar KS; DMPK, IVIVT, GlaxoSmithKline, Ware, UK., Upreti VV; Clinical Pharmacology Modeling and Simulation, Amgen Inc., South San Francisco, California, USA., Weber B; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Cook J; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Nov; Vol. 110 (5), pp. 1172-1175. Date of Electronic Publication: 2021 May 15. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33991429 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Galluppi+GR%22">Galluppi GR</searchLink>; Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Brar+S%22">Brar S</searchLink>; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Caro+L%22">Caro L</searchLink>; Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Drug Metabolism and Pharmacokinetics, Genentech Inc., a member of the Roche Group, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Frey+N%22">Frey N</searchLink>; Roche Pharma Research and Exploratory Development, Pharmaceutical Science, Roche Innovation Center, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grimm+HP%22">Grimm HP</searchLink>; Roche Pharma Research and Exploratory Development, Pharmaceutical Science, Roche Innovation Center, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rudd+DJ%22">Rudd DJ</searchLink>; Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Li+CC%22">Li CC</searchLink>; Department of Clinical Pharmacology, Genentech, member of the Roche group, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Magee+M%22">Magee M</searchLink>; GlaxoSmithKline, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Mukherjee+A%22">Mukherjee A</searchLink>; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Nagao+L%22">Nagao L</searchLink>; Faegre Drinker Biddle & Reath, LLP, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Purohit+VS%22">Purohit VS</searchLink>; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Roy+A%22">Roy A</searchLink>; Bristol Myers, Inc., Woodbury, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Salem+AH%22">Salem AH</searchLink>; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, Illinois, USA.; Ain Shams University, Cairo, Egypt.<br /><searchLink fieldCode="AU" term="%22Sinha+V%22">Sinha V</searchLink>; Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Suleiman+AA%22">Suleiman AA</searchLink>; Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Taskar+KS%22">Taskar KS</searchLink>; DMPK, IVIVT, GlaxoSmithKline, Ware, UK.<br /><searchLink fieldCode="AU" term="%22Upreti+VV%22">Upreti VV</searchLink>; Clinical Pharmacology Modeling and Simulation, Amgen Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Weber+B%22">Weber B</searchLink>; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Cook+J%22">Cook J</searchLink>; Clinical Pharmacology, Global Product Development, Pfizer Inc., Groton, Connecticut, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2021 Nov; Vol. 110 (5), pp. 1172-1175. <i>Date of Electronic Publication: </i>2021 May 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33991429 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.2265 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1172 Titles: – TitleFull: Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Galluppi GR – PersonEntity: Name: NameFull: Brar S – PersonEntity: Name: NameFull: Caro L – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Frey N – PersonEntity: Name: NameFull: Grimm HP – PersonEntity: Name: NameFull: Rudd DJ – PersonEntity: Name: NameFull: Li CC – PersonEntity: Name: NameFull: Magee M – PersonEntity: Name: NameFull: Mukherjee A – PersonEntity: Name: NameFull: Nagao L – PersonEntity: Name: NameFull: Purohit VS – PersonEntity: Name: NameFull: Roy A – PersonEntity: Name: NameFull: Salem AH – PersonEntity: Name: NameFull: Sinha V – PersonEntity: Name: NameFull: Suleiman AA – PersonEntity: Name: NameFull: Taskar KS – PersonEntity: Name: NameFull: Upreti VV – PersonEntity: Name: NameFull: Weber B – PersonEntity: Name: NameFull: Cook J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2021 Nov Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 110 – Type: issue Value: 5 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |